ArticleKidney research and clinical practice2022

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression.

Hyunsuk Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.